The laboratory and the direct oral anticoagulants

被引：84
|
作者：
Tripodi, Armando [1 ,2 ]
机构：
[1] Univ Milan, Dept Clin Sci & Community Hlth, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] Ist Ric & Cura Carattere Sci Ca Granda Osped Magg, Milan, Italy
来源：
BLOOD | 2013年 / 121卷 / 20期
关键词：
DIRECT THROMBIN INHIBITOR; DABIGATRAN ETEXILATE; CHROMOGENIC ASSAY; PROTHROMBIN TIME; RIVAROXABAN; PLASMA; RECOMMENDATIONS; IMPACT;
D O I：
10.1182/blood-2012-12-453076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Although direct oral anticoagulants do not need laboratory testing for dose adjustment, there are instances when laboratory measurement of the drug anticoagulant effect may be useful. They include before initiation of treatment, before surgical or invasive procedures, on the occasion of hemorrhagic or thrombotic events, and whenever immediate reversal of anticoagulation is needed. Choice of tests should be primarily based on their prompt availability. Accordingly, the dilute-thrombin or the ecarin clotting times are best suited for dabigatran and the prothrombin time or the anti-FXa for rivaroxaban.
引用
收藏
页码：4032 / 4035
页数：4
相关论文
共 50 条
  • [31] Hemorrhagic Complication and Its Laboratory Evaluation in Patients Receiving Direct Oral Anticoagulants
    Xie, Ming
    Edupuganti, Subhash
    Xie, Catherine
    Wyrzykowski, Mary
    Wey, Elizabeth
    MODERN PATHOLOGY, 2017, 30 : 386A - 387A
  • [32] Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
    Lessire, Sarah
    Douxfils, Jonathan
    Dincq, Anne-Sophie
    Mullier, Francois
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2016, 41 (06) : 787 - 788
  • [33] Direct Oral Anticoagulants Correlation of Laboratory Monitoring With Safe Interventional Pain Procedures
    Benzon, Honorio T.
    Lindholm, Paul F.
    Huntoon, Marc A.
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2016, 41 (02) : 123 - 124
  • [34] Hemorrhagic Complication and Its Laboratory Evaluation in Patients Receiving Direct Oral Anticoagulants
    Xie, Ming
    Edupuganti, Subhash
    Xie, Catherine
    Wyrzykowski, Mary
    Wey, Elizabeth
    LABORATORY INVESTIGATION, 2017, 97 : 386A - 387A
  • [35] Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (02) : 185 - 197
  • [36] Combined Administration of Antibiotics and Direct Oral Anticoagulants: A Renewed Indication for Laboratory Monitoring?
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    Mattiuzzi, Camilla
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (07): : 756 - 765
  • [37] Direct oral anticoagulants and antiplatelet agents Clinical relevance and options for laboratory testing
    Sibbing, D.
    Spannagl, M.
    HAMOSTASEOLOGIE, 2014, 34 (01): : 78 - 84
  • [38] Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
    Douxfils, J.
    Ageno, W.
    Samama, C. -M.
    Lessire, S.
    ten Cate, H.
    Verhamme, P.
    Dogne, J. -M.
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (02) : 209 - 219
  • [39] Laboratory measurement of the direct oral anticoagulants: Indications and impact on management in clinical practice
    Wright, C.
    Brown, R.
    Cuker, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 31 - 36
  • [40] Direct Oral Anticoagulants and Women
    Cohen, Hannah
    Arachchillage, Deepa R. J.
    Beyer-Westendorf, Jan
    Middeldorp, Saskia
    Kadir, Rezan A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (07): : 789 - 797
12345